1. Home
  2. EDIT vs ACU Comparison

EDIT vs ACU Comparison

Compare EDIT & ACU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Editas Medicine Inc.

EDIT

Editas Medicine Inc.

HOLD

Current Price

$2.86

Market Cap

206.0M

Sector

Health Care

ML Signal

HOLD

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$42.12

Market Cap

175.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDIT
ACU
Founded
2013
1867
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
206.0M
175.3M
IPO Year
2016
1994

Fundamental Metrics

Financial Performance
Metric
EDIT
ACU
Price
$2.86
$42.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$4.92
$50.00
AVG Volume (30 Days)
1.6M
16.8K
Earning Date
05-11-2026
04-23-2026
Dividend Yield
N/A
1.52%
EPS Growth
37.50
1.63
EPS
N/A
2.49
Revenue
$31,937,000.00
$196,541,816.00
Revenue This Year
N/A
$5.67
Revenue Next Year
N/A
$5.25
P/E Ratio
N/A
$16.67
Revenue Growth
132.64
1.05
52 Week Low
$1.29
$35.50
52 Week High
$4.54
$47.31

Technical Indicators

Market Signals
Indicator
EDIT
ACU
Relative Strength Index (RSI) 48.33 37.82
Support Level $1.95 $39.29
Resistance Level $3.17 $44.31
Average True Range (ATR) 0.26 1.48
MACD -0.05 -0.39
Stochastic Oscillator 17.95 3.76

Price Performance

Historical Comparison
EDIT
ACU

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

Share on Social Networks: